Longitudinal humoral immune response against COVID-19 adenovirus-based vaccines in patients with multiple sclerosis from Argentina undergoing immunosuppressive treatment

被引：0

作者：

Silva, B. A. ^{[1
,2
,3
]}

Miglietta, E. ^{[2
]}

Eizaguirre, B. ^{[1
]}

Alonso, R. ^{[1
]}

Wenker, S. ^{[2
]}

Casabona, J. C. ^{[2
]}

Casas, M. ^{[1
]}

Lazaro, L. ^{[1
]}

Cohen, L. ^{[1
]}

Pita, C. ^{[1
]}

Man, F. ^{[4
]}

Portuondo, G. ^{[4
]}

Bisso, A. Lopez ^{[4
]}

Zabala, N. ^{[4
]}

Casales, F. ^{[5
]}

Imhoff, G. ^{[6
]}

Steinberg, J. ^{[6
]}

Lopez, P. ^{[7
]}

Contentti, E. Carnero ^{[7
]}

Deri, N. ^{[8
]}

Sinay, V. ^{[9
]}

Hryb, J. ^{[10
]}

Chiganer, E. ^{[10
]}

Leguizamon, F. ^{[11
]}

Tkachuk, V. ^{[12
]}

Bauer, J. ^{[13
]}

Giachello, S. ^{[14
]}

Henestroza, P. ^{[14
]}

Garcea, O. ^{[1
]}

Vinzon, S. ^{[15
]}

Podhajcer, O. ^{[15
]}

Pitossi, F. ^{[2
]}

Ferrari, C. ^{[2
]}

机构：

[1] Hosp Ramos Mejia, Ctr Univ Esclerosis Multiple, Buenos Aires, Argentina

[2] Leloir Inst Fdn, Lab Terapias Regenerat Protectoras Sistema, Buenos Aires, Argentina

[3] Hosp Italiano Buenos Aires, Secc Enfermedades Desmielinizantes, Buenos Aires, DF, Argentina

[4] Hosp Ramos Mejia, Serv Neurol, Buenos Aires, DF, Argentina

[5] Sanatorio Arcos, Serv Neurol, Buenos Aires, Argentina

[6] Hosp Britanico, Serv Neuro, Buenos Aires, Argentina

[7] Hosp Aleman, Unidad Neuroinmunol, Buenos Aires, Argentina

[8] DIABAID, Buenos Aires, Argentina

[9] Fdn Favaloro, Buenos Aires, Argentina

[10] Hosp Durand, Consult Neuroinmunol Clin, Buenos Aires, Argentina

[11] Hosp Alvarez, Buenos Aires, Argentina

[12] Hosp Clin Buenos Aires, Clin Enfermedades Desmielinizantes, Buenos Aires, Argentina

[13] Esclerosis Multiple Argentina, Buenos Aires, Argentina

[14] Asociac Lucha Esclerosis Multiple, San Antonio, Argentina

[15] Leloir Inst Fdn, Lab Terapia Mol & Celular, Buenos Aires, Argentina

来源：

MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EP1094

引用

页码：868 / 868

页数：1

共 50 条

[21] Humoral immune response after COVID-19 in multiple sclerosis: a nation-wide Austrian study
Bsteh, G.
Duerauer, S.
Assar, H.
Hegen, H.
Heschl, B.
Leutmezer, F.
Di Pauli, F.
Gradl, C.
Traxler, G.
Zulehner, G.
Rommer, P.
Wipfler, P.
Guger, M.
Hoeftberger, R.
Enzinger, C.
Berger, T.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 752 - 753
[22] Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study
Bsteh, Gabriel
Duerauer, Sophie
Assar, Hamid
Hegen, Harald
Heschl, Bettina
Leutmezer, Fritz
Di Pauli, Franziska
Gradl, Christiane
Traxler, Gerhard
Zulehner, Gudrun
Rommer, Paulus
Wipfler, Peter
Guger, Michael
Hoeftberger, Romana
Enzinger, Christian
Berger, Thomas
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (14) : 2209 - 2218
[23] Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease
Kappelman, Michael D.
Weaver, Kimberly N.
Boccieri, Margie
Firestine, Ann
Zhang, Xian
Long, Millie D.
GASTROENTEROLOGY, 2021, 161 (04) : 1340 - +
[24] Humoral vaccine response and COVID-19 hospitalizations in vaccinated multiple sclerosis patients treated with rituximab
Torgauten, H.
Onyangp, T.
Hallin, E.
Serkland, T.
Skrede, S.
Cox, R.
Langeland, N.
Myhr, K.
Torkildsen, O.
EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 736 - 736
[25] Obesity causes a delay in antibody response of adenovirus-based Covid-19 vaccines in C57BL/6 mice
Geissler, N.
Orola, M.
Nardo, A.
Stulnig, T.
Schmid, A.
Weinmayer, T.
Schabussova, I.
Inic-Kanada, A.
Wiedermann, U.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 325 - 325
[26] Three to four mRNA COVID-19 vaccines in multiple sclerosis patients on immunosuppressive drugs: Seroconversion and variant neutralization
Louapre, Celine
Belin, Lisa
Marot, Stephane
Hippolyte, Amandine
Januel, Edouard
Ibrahim, Michella
Jeantin, Lina
Zafilaza, Karen
Malet, Isabelle
Charbonnier-Beaupel, Fanny
Rosenzwajg, Michelle
Soulie, Cathia
Marcelin, Anne-Genevieve
Pourcher, Valerie
EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (09) : 2781 - 2792
[27] Humoral immune response to COVID-19 mRNA (BNT162b2-Pfizer) vaccine in patients with multiple sclerosis
Karussis, D.
Karni, A.
Milo, R.
Staun-Ram, E.
Miller, A.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 766 - 767
[28] Humoral Immune Response Against BNT162b2 mRNA COVID-19 Vaccine in Patients with Rheumatic Disease Undergoing Immunosuppressive Therapy: A Japanese Monocentric Study
Sugihara, Koichi
Wakiya, Risa
Kameda, Tomohiro
Shimada, Hiromi
Nakashima, Shusaku
Kato, Mikiya
Miyagi, Taichi
Mizusaki, Mao
Mino, Rina
Dobashi, Hiroaki
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1497 - 1499
[29] Humoral immune response against BNT162b2 mRNA COVID-19 vaccine in patients with rheumatic disease undergoing immunosuppressive therapy: A Japanese monocentric study
Sugihara, Koichi
Wakiya, Risa
Kameda, Tomohiro
Shimada, Hiromi
Nakashima, Shusaku
Kato, Mikiya
Miyagi, Taichi
Ushio, Yusuke
Mizusaki, Mao
Mino, Rina
Chujo, Kanako
Nomura, Yumi
Inoo, Masayuki
Kadowaki, Norimitsu
Dobashi, Hiroaki
MEDICINE, 2022, 101 (42) : E31288
[30] Humoral response to mRNA-based COVID-19 vaccine in patients with immune thrombocytopenia
Mori, Akio
Onozawa, Masahiro
Kobayashi, Mirei
Tsukamoto, Shihori
Senjo, Hajime
Ishio, Takashi
Yokoyama, Emi
Izumiyama, Koh
Saito, Makoto
Muraki, Haruna
Morioka, Masanobu
Teshima, Takanori
Kondo, Takeshi
BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (06) : 717 - 721

← 1 2 3 4 5 →